Pipeline Lundbeck to present new Vyepti and bocunebart data at EAN 2026 PharmaTimesLundbeck will present new migraine data at the European Academy of Neurology Congress 2026, taking place from 27-30 June in Geneva.NeuroscienceRead full story pharminent June 24, 2026 (Last updated: June 24, 2026) PharmaTimes Lundbeck will present new migraine data at the European Academy of Neurology Congress 2026, taking place from 27-30 June in Geneva. Neuroscience Read full story Post navigation Previous: URA and Lilly join forces to harmonise drug-wearable obesity careNext: SK pharmteco Launches SKyvec Viral Vector Platform for Gene Therapy Related Stories Pipeline Beyond GLP1s: The race for nextgen obesity drugs starts in the preclinical models pharminent September 2, 2026 Pipeline Bausch + Lomb advances dry eye disease drug to Phase 3 despite mid-stage fail pharminent August 25, 2026 Pipeline Chasing Dupixent, a biotech aims to make better antibody drugs for eczema pharminent August 11, 2026